VivoSeq
Psychiatry

Anxiety Disorders

1

Pipeline Programs↗

2

Active Trials↗

1

Companies Involved↗

Anxiety Disorders is an early-stage landscape with 1 program across 1 company. The most active players are Vitae Pharmaceuticals Inc., an Allergan affiliate.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

100/100

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

V

Vitae Pharmaceuticals Inc., an Allergan affiliate

1 program

Phase 2

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 21

Fluoxetine

Vitae Pharmaceuticals Inc., an Allergan affiliate

Phase 3
No programs
Approved
No programs

Analysis

Trial Status

5

clinical trials

Completed3 · 60%
Recruiting1 · 20%
Not yet recruiting1 · 20%

Clinical Trials

Trial Activity

Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
Recruiting·National Institute of Mental Health (NIMH)·Phase 2·NCT00018057·3,500 enrolled
Feasibility and Acceptability of Problem Management Plus (PM+) for Prisoners in the Netherlands - a Pilot Randomised Controlled Trial
Completed·VVU University of Amsterdam·Preclinical·NCT05927987·56 enrolled
Study of Slow Prefrontal Cortex Oscillations During Social Exposure in Social Anxiety Disorder
Completed·IInstitut National de la Santé Et de la Recherche Médicale, France·Preclinical·NCT03821779·20 enrolled
An Investigation of a Brief Psycho-Social Computerized Intervention Targeting the Error-Related Negativity and Balance N1 in Anxious Children
Completed·FFlorida State University·Preclinical·NCT05503017·248 enrolled
Randomized Controlled Trial of the BraveBot Intervention as an Adjunctive Treatment for Young People With Anxiety and Related Disorders Receiving Outpatient, Exposure-Based Cognitive Behavioral Therapy
Not yet recruiting·MMassachusetts General Hospital·Preclinical·NCT07666672·50 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)